Rezo Therapeutics Stock

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.

Sign up today and learn more about Rezo Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Rezo Therapeutics Stock

Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence. Rezo's proprietary platform can be used to treat a wide range of diseases. Rezo's initial focus is oncology, with plans to expand into other therapeutic areas through collaborations and partnerships.

Funding History

November 2022$78.0M

Management

Board Member

Tiba Aynechi

Board Member

Norbert Bischofberger

Board Member

Nevan Krogan

Board Member

Vineeta Agarwala

Board Member

George Scangos

Board Member

Simeon George

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo